Steven Cohen's CGON Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 151,363 shares of CG Oncology, Inc. (CGON) worth $6.28 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CGON for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 1.36 M shares. Largest reduction occurred in Q4 2025, reducing 1.37 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's CG Oncology (CGON) Holding Value Over Time
Track share changes against reported price movement
Quarterly CG Oncology (CGON) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.37 M | Reduce 90.06% | 151,363 | $41.52 |
| Q3 2025 | +48,116 | Add 3.26% | 1.52 M | $40.28 |
| Q2 2025 | -191,881 | Reduce 11.51% | 1.48 M | $26.00 |
| Q1 2025 | +1.36 M | Add 440.84% | 1.67 M | $24.49 |
| Q4 2024 | -437,804 | Reduce 58.68% | 308,259 | $28.68 |
| Q3 2024 | +635,653 | Add 575.72% | 746,063 | $37.73 |
| Q2 2024 | -75,827 | Reduce 40.72% | 110,410 | $31.57 |
| Q1 2024 | +186,237 | New Buy | 186,237 | $43.90 |
Steven Cohen's CG Oncology Investment FAQs
Steven Cohen first purchased CG Oncology, Inc. (CGON) in Q1 2024, acquiring 186,237 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held CG Oncology, Inc. (CGON) for 8 quarters since Q1 2024.
Steven Cohen's largest addition to CG Oncology, Inc. (CGON) was in Q1 2025, adding 1,667,174 shares worth $40.83 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 151,363 shares of CG Oncology, Inc. (CGON), valued at approximately $6.28 M.
As of the Q4 2025 filing, CG Oncology, Inc. (CGON) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in CG Oncology, Inc. (CGON) was 1,667,174 shares, as reported at the end of Q1 2025.